{"product_id":"vesugen","title":"Vesugen","description":"\u003ch2\u003e\u003cstrong\u003eVesugen Description\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"whitespace-normal break-words\"\u003eVesugen is a synthetic tripeptide bioregulator composed of three amino acids: lysine, glutamic acid, and aspartic acid (Lys-Glu-Asp). This Khavinson short peptide serves as a research tool for studying vascular function and cardiovascular system mechanisms. Laboratory studies suggest that Vesugen may influence vascular endothelial cells and blood vessel tissue responses.\u003c\/p\u003e\n\u003cp class=\"whitespace-normal break-words\"\u003eResearch applications include atherosclerosis studies, metabolic pathway analysis, and central nervous system vascular research. As part of the bioregulatory peptides family, this geroprotective compound enables controlled examination of cellular processes in vascular system research. For research use only.\u003c\/p\u003e\n\u003ch3 class=\"text-xl font-bold text-text-100 mt-1 -mb-0.5\"\u003ePeptide Bioregulator Information\u003c\/h3\u003e\n\u003ctable class=\"bg-bg-100 min-w-full border-separate border-spacing-0 text-sm leading-[1.88888] whitespace-normal\"\u003e\n\u003cthead class=\"border-b-border-100\/50 border-b-[0.5px] text-left\"\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003cth class=\"text-text-000 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eProperty\u003c\/th\u003e\n\u003cth class=\"text-text-000 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003ePeptide Sequence\u003c\/td\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eH-Lys-Glu-Asp-OH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eC₁₅H₂₆N₄O₈\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003e390.39 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eCAS Number\u003c\/td\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"[tbody\u0026gt;\u0026amp;]:odd:bg-bg-500\/10\"\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003ePubChem CID\u003c\/td\u003e\n\u003ctd class=\"border-t-border-100\/50 [\u0026amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [\u0026amp;:not(:first-child)]:border-l-[0.5px]\"\u003e87571363\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 24px;\"\u003eVesugen Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is the research background of Vesugen?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVesugen is a peptide complex developed by the Institute of Bioregulation and Gerontology in St. Petersburg, Russia. It was developed against the backdrop that cardiovascular diseases have become one of the main causes of disability and shortened lifespan worldwide. Changes in the blood vessel wall, alterations in blood flow, and insufficient absorption of nutrients by tissues are potential etiologies of such diseases. Vesugen is designed to correct the vascular pathological changes caused by various diseases, and the amino acids it contains contribute to tissue repair and the normalization of vascular function.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is the mechanism of action of Vesugen?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Effects on Cell Proliferation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStimulating the Synthesis of Ki-67 Protein: The short peptide Vesugen can stimulate the synthesis of the proliferation-related protein Ki-67. In tissue-specific cell cultures obtained from young and old animals, as well as in cultures of isolated vascular endothelial cells, the expression of Ki-67 decreases with age, and Vesugen can reverse this trend (Khavinson V K, 2015). Through molecular docking methods, it was found that Vesugen interacts with the promoter region of the MKI67 gene encoding the Ki-67 protein. Specifically, Vesugen contacts the core promoter 5'-agcctcaaccatcaggaaaacaagagt-3', which is located in the MKI67 gene from -14 to +12 base pairs relative to the transcription initiation site, through the sequence CATC, thus achieving epigenetic regulation of Ki-67 gene expression. This indicates that Vesugen may promote cell proliferation by regulating gene expression\u003csup\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eEnhancing the Proliferation Potential of Cells: In the study of immune cells in the pineal gland, it was found that the tripeptide Vesugen, although it has no effect on the differentiation ability of immune cells in the pineal gland, enhances their proliferation potential\u003csup\u003e[2]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Vascular Protective Effect in the Elderly Population\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVascular Protection Achieved through Epigenetic Regulation: The previously revealed vascular protective effect of the peptide Vesugen in the elderly can be achieved through the epigenetic regulation of Ki-67 gene expression. The Ki-67 protein plays an important role in cell proliferation, and Vesugen's regulation of its expression may help maintain the proliferation ability of vascular endothelial cells, thus playing a role in vascular protection\u003csup\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003ch4\u003e3. Effects on Patients with Chronic Multimorbidity and Organic Brain Syndrome of the Central Nervous System\u003c\/h4\u003e\n\u003cp\u003eSignificant Anabolic Effects: In a study of 32 patients aged 41 - 83 years with multimorbidity and in the remission stage of organic brain syndrome of the central nervous system, it was found that the preparations \"Pinealon\" and \"Vesugen\" have significant anabolic effects. They improved the activity of the central nervous system and other important organs and slowed down the aging rate through biological age indicators. Moreover, Vesugen showed a more obvious anti-aging preventive effect than Pinealon\u003csup\u003e[3]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eNo Impact on Chromatin Condensation: The study found that Pinealon and Vesugen did not affect the degree of chromatin condensation, indicating that they are safe at the nuclear genetic level \u003csup\u003e[3]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat are the applications of Vesugen?\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e1. Anti-aging\u003c\/h4\u003e\n\u003cp\u003eCellular Anti-aging: Vesugen can activate the sirtuin 1 protein, simulate the effects of calorie restriction, reduce apoptosis, and decrease the rate of cellular aging \u003csup\u003e[3]\u003c\/sup\u003e. Cellular aging leads to the decline of tissue and organ functions and increases the risk of aging-related diseases. The sirtuin 1 protein is an important anti-aging protein that can regulate the metabolic pathways within cells, enhance the antioxidant capacity of cells, and scavenge free radicals. After activating the sirtuin 1 protein, Vesugen can improve the survival ability of cells and delay the aging process of cells.\u003c\/p\u003e\n\u003cp\u003eOverall Anti-aging: Through the protective and reparative effects on multiple tissues and organs such as the vascular system and the nervous system, Vesugen helps maintain the overall function of the body, delays the occurrence of aging-related diseases, and improves the healthy lifespan of the body\u003csup\u003e[3]\u003c\/sup\u003e. Aging-related diseases such as cardiovascular diseases, neurological diseases, and metabolic diseases can seriously affect the healthy lifespan of the body. Through its protective and reparative effects on multiple tissues and organs, Vesugen can reduce the risk of aging-related diseases and improve the healthy lifespan of the body.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Prevention and Treatment of Cardiovascular Diseases\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImproving Vascular Function: Vesugen can promote the repair and regeneration of endothelial cells. Endothelial cells are an important component of the inner wall of blood vessels, and their damage can lead to vascular dysfunction. Vesugen improves vascular elasticity and reduces vascular resistance by regulating the balance of vasodilator and vasoconstrictor factors, such as nitric oxide (NO) and endothelin \u003csup\u003e[3]\u003c\/sup\u003e. This helps prevent and improve vascular dysfunctional diseases such as hypertension and arteriosclerosis. Hypertension and arteriosclerosis are major risk factors for cardiovascular diseases, and this effect of Vesugen is of great significance for reducing the risk of cardiovascular diseases.\u003c\/p\u003e\n\u003cp\u003eAnti-atherosclerosis: Atherosclerosis is one of the main pathological bases of cardiovascular diseases. Vesugen prevents the formation and development of atherosclerotic plaques by inhibiting the inflammatory response, reducing oxidative stress damage, and regulating lipid metabolism\u003csup\u003e[3]\u003c\/sup\u003e. The inflammatory response and oxidative stress play a key role in the occurrence and development of atherosclerosis. Vesugen can inhibit the release of inflammatory factors, such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), etc., and reduce the generation of oxidative stress products, such as reactive oxygen species (ROS), etc. In addition, Vesugen can also regulate lipid metabolism, reduce the level of low-density lipoprotein cholesterol (LDL-C), and increase the level of high-density lipoprotein cholesterol (HDL-C), thus reducing the risk of cardiovascular diseases.\u003c\/p\u003e\n\u003cp\u003eMyocardial Protection: Under pathological conditions such as myocardial ischemia and hypoxia, Vesugen can reduce the apoptosis and necrosis of myocardial cells and increase the survival rate of myocardial cells by activating related signaling pathways \u003csup\u003e[3]\u003c\/sup\u003e. Diseases such as myocardial infarction and heart failure can lead to a large number of deaths of myocardial cells, affecting the function of the heart. Vesugen can activate the survival signaling pathways within cells, such as the phosphatidylinositol 3-kinase\/protein kinase B (PI3K\/Akt) pathway and the mitogen-activated protein kinase (MAPK) pathway, and inhibit the apoptosis signaling pathway, such as the caspase pathway, etc., thus protecting myocardial cells. This helps improve the prognosis of diseases such as myocardial infarction and heart failure.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. Treatment of Nervous System Diseases\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNeuroprotection: Vesugen has a protective effect on neurons, which can increase the survival rate of neurons and reduce the damage of nerve cells\u003csup\u003e[3]\u003c\/sup\u003e. Neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease can lead to a large number of deaths of neurons, affecting the function of the nervous system. Vesugen can inhibit the apoptosis of nerve cells by regulating the signaling pathways within nerve cells, such as regulating the expression of B-cell lymphoma-2 (Bcl-2) family proteins and inhibiting the caspase pathway. In addition, Vesugen can also improve the antioxidant capacity of nerve cells and reduce the damage of oxidative stress to nerve cells.\u003c\/p\u003e\n\u003cp\u003ePromoting Nerve Regeneration: This drug can also promote the growth and regeneration of nerve axons and improve nerve function. In the rehabilitation treatment of diseases such as peripheral nerve injury and stroke, Vesugen may help promote the recovery of nerve function and improve the quality of life of patients. The growth and regeneration of nerve axons are key links in the repair of the nervous system. Vesugen can activate the expression of nerve growth factors (NGF) and other neurotrophic factors, promoting the growth and regeneration of nerve axons. In addition, Vesugen can also regulate the microenvironment of nerve cells, such as reducing the inflammatory response and promoting the supportive role of glial cells, creating favorable conditions for nerve regeneration.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Intervention in Metabolic Diseases\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImproving Insulin Sensitivity: After activating the sirtuin 1 protein, Vesugen can improve insulin sensitivity, help cells better absorb and utilize glucose, and thus reduce blood sugar levels\u003csup\u003e[3]\u003c\/sup\u003e. Type 2 diabetes is a common metabolic disease, and its main characteristics are insulin resistance and elevated blood sugar. Vesugen can improve insulin sensitivity and reduce blood sugar levels, which is of great significance for the prevention and treatment of type 2 diabetes and its complications.\u003c\/p\u003e\n\u003cp\u003eRegulating Lipid Metabolism: This drug can also regulate the expression of genes related to lipid metabolism, promote the oxidative decomposition of fatty acids, and reduce the accumulation of fat in the body, which helps improve metabolic diseases such as hyperlipidemia and obesity \u003csup\u003e[3]\u003c\/sup\u003e. Hyperlipidemia and obesity are major risk factors for metabolic diseases, which will increase the risk of diseases such as cardiovascular diseases and diabetes. Vesugen can regulate the expression of genes related to lipid metabolism, such as peroxisome proliferator-activated receptor (PPAR), etc., promote the oxidative decomposition of fatty acids, and reduce the accumulation of fat in the body, thus reducing the risk of metabolic diseases.\u003c\/p\u003e\n\u003cp\u003eIn conclusion, Vesugen can promote cell repair and regeneration, regulate metabolism, and delay aging, which is of great significance for the prevention and treatment of cardiovascular, nervous system diseases, and the improvement of health levels.\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cstrong style=\"font-size: 24px;\"\u003eRelevant Citations\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e[1]    Khavinson V K, Tarnovskaya S I, Linkova N S, et al. Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation in aging[J]. Advances in Gerontology, 2015,5(4):219-224.DOI:10.1134\/S2079057015040116.\u003c\/p\u003e\n\u003cp\u003e[2]    Linkova N S, Khavinson V K, Chalisova N I, et al. Peptidegic Stimulation of Differentiation of Pineal Immune Cells[J]. Bulletin of Experimental Biology and Medicine, 2011,152(1):124-127.DOI:10.1007\/s10517-011-1470-1.\u003c\/p\u003e\n\u003cp\u003e[3]    Meshchaninov V N, Tkachenko E L, Zharkov S V, et al. Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome of the central nervous system in remission.[J]. Advances in Gerontology = Uspekhi Gerontologii, 2015,28 1:62-67. https:\/\/api.semanticscholar.org\/CorpusID:24149000.\u003c\/p\u003e\n\u003cp data-start=\"293\" data-end=\"654\"\u003e\u003cstrong\u003eFor Research Use Only\u003c\/strong\u003e\u003cbr data-start=\"321\" data-end=\"324\"\u003eThis compound is provided exclusively for in vitro laboratory research. It is not intended for human or animal consumption, diagnosis, treatment, or medical use. Not for dietary, cosmetic, or veterinary purposes. This product has not been evaluated by the U.S. Food and Drug Administration or any other regulatory authority.\u003c\/p\u003e\n\u003chr data-start=\"656\" data-end=\"659\"\u003e\n\u003cp data-start=\"661\" data-end=\"910\"\u003e\u003cstrong\u003eDisclaimer\u003c\/strong\u003e\u003cbr data-start=\"675\" data-end=\"678\"\u003eAll information is for educational purposes only. Humatide makes no claims regarding efficacy or safety. Purchasers are responsible for ensuring proper handling and use in compliance with all applicable laws and regulations.\u003c\/p\u003e\n\u003chr data-start=\"912\" data-end=\"915\"\u003e\n\u003cp data-start=\"917\" data-end=\"1259\"\u003e\u003cstrong\u003eTerms of Sale\u003c\/strong\u003e\u003cbr data-start=\"934\" data-end=\"937\"\u003eBy purchasing from Humatide, you confirm that you are a qualified researcher with the knowledge and facilities to safely handle and store research chemicals. All sales are final. Humatide assumes no liability for misuse, misrepresentation, or unintended consequences arising from the use of this product.\u003c\/p\u003e","brand":"Humatide","offers":[{"title":"20MG","offer_id":46064740630718,"sku":null,"price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0748\/8667\/6670\/files\/Vesugen.jpg?v=1781293861","url":"https:\/\/shop.humatide.com\/products\/vesugen","provider":"Humatide","version":"1.0","type":"link"}